Unknown. EALegit has not audited Botralix. A listing is not a verdict that it is legit.

Has EALegit independently reviewed Botralix?

Not yet. Listing is seller materials. The owner can submit source from For developers.

Does Botralix use grid or martingale?

Seller materials do not claim grid or martingale. Not audited — we have not confirmed the code.

Can I trust the seller backtest?

No usable seller baseline is published and we have no lab replay. Treat the seller backtest as untested marketing.

Unaudited seller listing — lab verdict pending

Untrusted tick model

This listing is built from seller materials. Lab replay not yet executed. Lab, audit, live tracking and verified reviews stay empty until we compile and run real-tick replay.

Submit source if you own this EA

Seller price $349

Curve replay

Backtest vs lab reality

Zero corroboration

Seller marketing curve (claimed)Lab replay not run

Execution engine locked

Real-tick replay has not run for this listing.

Claimed profit factor

— (marketing)

Real-tick PF

Pending

Seller price: $349

Submit source if you own this EA View on MQL5 ↗

Botralix2.0

Developed byKai Yang Ang1 EA on record

View on MQL5 ↗

Not testedBreakoutXAUUSDH1MetaTrader 5

Seller claims

grid no · martingale no · SL yes

EALegit summary — unaudited listing

Botralix is a MetaTrader 5 expert advisor built exclusively for XAUUSD (Gold) on the H1 timeframe. It is a breakout system: it waits for a consolidation range to form, places orders at the range edges, and applies multiple quality filters before entry, including an MQL5 news filter, spread guard, and session filter. Risk management relies on a fixed stop loss per trade, an early adverse exit that closes trades before the full SL if price reverses, a four-stage profit protection with breakeven and trailing, and circuit-breaker pauses that halt entries in poor conditions. The seller states the EA does not use grid or martingale, uses risk-percentage-based auto lot sizing, and auto-closes positions on Friday to avoid weekend gap risk.

Reviews

No reviews yet.